Analysis of pharmacogenetic traits in two distinct South African populations
about
Pharmacokinetic, Pharmacogenetic, and Other Factors Influencing CNS Penetration of AntiretroviralsGenetic polymorphisms and haplotypes of the organic cation transporter 1 gene (SLC22A1) in the Xhosa population of South AfricaIntroduction of the AmpliChip CYP450 Test to a South African cohort: a platform comparative prospective cohort studyPharmacogenomic Research in South Africa: Lessons Learned and Future Opportunities in the Rainbow Nation.Effects of CYP2B6 and CYP1A2 Genetic Variation on Nevirapine Plasma Concentration and Pharmacodynamics as Measured by CD4 Cell Count in Zimbabwean HIV-Infected Patients.ABCB1 4036A>G and 1236C>T Polymorphisms Affect Plasma Efavirenz Levels in South African HIV/AIDS Patients.An Expanded Analysis of Pharmacogenetics Determinants of Efavirenz Response that Includes 3'-UTR Single Nucleotide Polymorphisms among Black South African HIV/AIDS PatientsPXR and CAR single nucleotide polymorphisms influence plasma efavirenz levels in South African HIV/AIDS patients.Characterization of the genetic variation present in CYP3A4 in three South African populations.CYP2B6*6 and CYP2B6*18 Predict Long-Term Efavirenz Exposure Measured in Hair Samples in HIV-Positive South African WomenMedroxyprogesterone acetate levels among Kenyan women using depot medroxyprogesterone acetate in the FEM-PrEP trial.Cytochrome P450 pharmacogenetics in African populations.Priority pharmacogenetics for the African continent: focus on CYP450.Cytochrome P450 pharmacogenetics in African populations: implications for public health.Pharmacogenetics of CYP2B6, CYP2A6 and UGT2B7 in HIV treatment in African populations: focus on efavirenz and nevirapine.Genetic Polymorphisms Affecting the Pharmacokinetics of Antiretroviral Drugs.Genetic variants in CYP (-1A2, -2C9, -2C19, -3A4 and -3A5), VKORC1 and ABCB1 genes in a black South African population: a window into diversity.Characterization of CYP1A2, CYP2C19, CYP3A4 and CYP3A5 polymorphisms in South Brazilians.Pharmacogenetic considerations for HIV treatment in different ethnicities: an update.Evaluation of predictiveCYP2C19genotyping assays relative to measured phenotype in a South African cohort
P2860
Q28069383-BC13DDF7-765E-4D7B-A212-2AA4F60A0BA5Q33890370-AA6CAA29-4A30-4357-808E-1C5AE694F80BQ34565428-D4A4F672-FBB8-4361-9A85-76BE4FFDF7B3Q35584999-7E529D06-8443-420F-9BA4-B0374A2E8A79Q36074119-4EC126DA-59CF-4478-9DCF-268FE77F38E6Q36370484-E47A1C79-F86A-49DC-BD8F-CAB3CE44E16AQ36437792-2790F168-0238-4CA5-B3A9-FCA73788E9A9Q36468872-F5E11A25-58FE-4633-ADFC-1442F319C437Q36617170-A12706D1-7C25-4D68-B0EF-805383569DF3Q36966640-D8433263-BD3E-4BF3-BA08-FBBC55C7EBF9Q36973336-036AFDC1-E287-4ED3-A0AD-71C4F700D1D7Q38099372-50044759-2A92-435E-B45C-ADA5C7BAB861Q38188600-0724BF8B-86AF-455E-BB1F-056C25C03739Q38192688-C8A36CFE-D5B0-46B5-BB46-367F163E21AFQ38267710-6FBA8A3E-EFD8-46CA-B80C-3E7DE499DF1AQ38957969-7FD235F8-BD3F-4829-94D2-6C91B8404386Q43879115-6A09AE2C-2F94-46C3-B97F-AA68E1810D43Q44502093-07DC5345-B00F-40E2-AA5A-DAC331476412Q47906608-7C20A631-CE50-4700-A0B0-780AD1E67762Q59205492-93081473-D8D9-4B96-8336-9E5C1876FA44
P2860
Analysis of pharmacogenetic traits in two distinct South African populations
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Analysis of pharmacogenetic traits in two distinct South African populations
@ast
Analysis of pharmacogenetic traits in two distinct South African populations
@en
type
label
Analysis of pharmacogenetic traits in two distinct South African populations
@ast
Analysis of pharmacogenetic traits in two distinct South African populations
@en
prefLabel
Analysis of pharmacogenetic traits in two distinct South African populations
@ast
Analysis of pharmacogenetic traits in two distinct South African populations
@en
P2093
P2860
P1433
P1476
Analysis of pharmacogenetic traits in two distinct South African populations
@en
P2093
Bradley Aouizerat
Monica Gandhi
Ogechi Ikediobi
Stefan Gebhardt
Yuanyuan Xiao
P2860
P2888
P304
P356
10.1186/1479-7364-5-4-265
P577
2011-05-01T00:00:00Z
P5875
P6179
1047591322